BioPharma Credit PLC (BPCP.L) Stock Price
£66.2 0%
to add to portfolio
AI Score

-
Alternative
9 -
Fundamental
8 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on BioPharma Credit PLC, AI stock picks, stock alerts and much more.
BPCP.L AI Stock Analysis
AI stock analysis for BPCP.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like BioPharma Credit PLC (BPCP.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
BioPharma Credit PLC (BPCP.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of BioPharma Credit PLC (BPCP.L), currently trading at £66.2, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About BPCP.L

-
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets.
-
Symbol
BPCP.L
-
Market
LSE
-
Industry
Asset Management
-
Market Cap
747.6M
Similar Stocks
![]() |
M&G MNG.L |
£268.2 0.3% |
5 |
![]() |
Ameriprise Financial 0HF6.L |
$513.7 2.2% |
6 |
![]() |
Scottish Mortgage Investment Trust PLC SMT.L |
£1095 2.2% |
6 |
![]() |
The Renewables Infrastructure Group Limited TRIG.L |
£79.4 0.6% |
5 |
![]() |
IP Group Plc IPO.L |
£61.2 2.3% |
6 |
BPCP.L Alternative Data
Web Traffic
BioPharma Credit PLC receives an estimated 2819 monthly visitors to bpcruk.com.
-
Web Traffic
2819
-
Change from Previous Month
58%
-
3 Month Change
400.7%
-
YoY Change
400.7%
Reddit Mentions
BioPharma Credit PLC has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
News Mentions
BioPharma Credit PLC was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
BPCP.L Financials
BPCP.L Key Metrics
-
Total Revenue
$39.6M
-
Net Income
$35.9M
-
Earnings per Share
$0.0288
-
Free cash flow
$23.8M
-
EBITDA
$44.5K
-
EBITDA Ratio
0.00112452
-
Total Assets
$1.2B
BPCP.L 2-year Revenue & Income
BPCP.L 2-year Free Cash Flow
BPCP.L Technicals
BPCP.L SMA
BPCP.L RSI
FAQ
What's the current price of BioPharma Credit PLC (BPCP.L) Stock?
The price of an BioPharma Credit PLC (BPCP.L) share is £66.2.
What's the market cap of BioPharma Credit PLC?
The current market cap of BioPharma Credit PLC is 747.6M.
Should I buy or sell BPCP.L?
Multiple alternative data signals suggest that BioPharma Credit PLC stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is BioPharma Credit PLC a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in BioPharma Credit PLC stock. The bullish indicators suggest that BioPharma Credit PLC's growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy BioPharma Credit PLC (BPCP.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying BioPharma Credit PLC stock, given the bullish outlook.
What are some stocks similar to BioPharma Credit PLC (BPCP.L) that investors often compare it to?
BioPharma Credit PLC (BPCP.L) is often compared to similar stocks such as M&G, Ameriprise Financial, Scottish Mortgage Investment Trust PLC, The Renewables Infrastructure Group Limited and IP Group Plc.
What is the forecast for BioPharma Credit PLC's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast BioPharma Credit PLC's stock price to be around £72.84 in 2026. Starting from the current price of £66.2, this represents a 10% change in price, indicating a bullish outlook for the stock.
How to buy BioPharma Credit PLC (BPCP.L) Stock?
BioPharma Credit PLC stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy BioPharma Credit PLC shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.